AAWH (Ascend Wellness Holdings) Days Payable: 29.63 (As of Mar. 2026) — 14% Above Median


AAWH Ascend Wellness Holdings Inc AAWH
42 GF Score
Price $0.47
GF Value $0.64
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Ascend Wellness Holdings Days Payable?

Ascend Wellness Holdings AAWH +4.61% 42 Days Payable is 29.63 as of Mar. 2026, which is 14% above its 10-year median of 26.04. GuruFocus rates AAWH with a GF Score™ of 42/100 and a GF Value™ of $0.64 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 920 Drug Manufacturers companies, Ascend Wellness Holdings ranks worse than 90.87% on this metric.

Ascend Wellness Holdings's average Accounts Payable for the three months ended in Mar. 2026 was $23.4 Mil. Ascend Wellness Holdings's Cost of Goods Sold for the three months ended in Mar. 2026 was $72.1 Mil. Hence, Ascend Wellness Holdings's Days Payable for the three months ended in Mar. 2026 was 29.63.

The historical rank and industry rank for Ascend Wellness Holdings's Days Payable or its related term are showing as below:

AAWH' s Days Payable Range Over the Past 10 Years
Min: 11.99   Med: 26.04   Max: 32.45
Current: 28.41

During the past 7 years, Ascend Wellness Holdings's highest Days Payable was 32.45. The lowest was 11.99. And the median was 26.04.

AAWH's Days Payable is ranked worse than
90.87% of 920 companies
in the Drug Manufacturers industry
Industry Median: 90.835 vs AAWH: 28.41

Ascend Wellness Holdings's Days Payable increased from Mar. 2025 (28.73) to Mar. 2026 (29.63). It may suggest that Ascend Wellness Holdings delayed paying its suppliers.


Ascend Wellness Holdings Days Payable Historical Data

* Premium members only.

The historical data trend for Ascend Wellness Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascend Wellness Holdings Days Payable Chart

Ascend Wellness Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial 11.99 15.20 25.98 29.55 26.10

Ascend Wellness Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.73 27.53 26.07 27.05 29.63

AAWH vs ZTS: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ascend Wellness Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascend Wellness Holdings Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ascend Wellness Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Ascend Wellness Holdings's Days Payable falls into.


AAWH
42GF Score
Ascend Wellness Holdings Inc AAWH
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascend Wellness Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Ascend Wellness Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (26.414 + 20.912) / 2 ) / 330.901*365
=23.663 / 330.901*365
=26.10

Ascend Wellness Holdings's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (20.912 + 25.88) / 2 ) / 72.051*365 / 4
=23.396 / 72.051*365 / 4
=29.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 29.63 mean?
Ascend Wellness Holdings (AAWH) has a Days Payable of 29.63 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ascend Wellness Holdings and its competitors. This is 14% above median its historical median of 26.04. Over the past decade, Ascend Wellness Holdings' Days Payable has ranged from 11.99 to 32.45. According to the industry distribution chart, Ascend Wellness Holdings ranks #836 out of 920 companies in the Drug Manufacturers industry, placing it in the top 90.9%.
Is Ascend Wellness Holdings' Days Payable too high?
Ascend Wellness Holdings' current Days Payable of 29.63 is 14% above median its 10-year median of 26.04. Over the past 10 years, this metric has ranged from a low of 11.99 to a high of 32.45. The Drug Manufacturers industry median Days Payable is 90.84. Ascend Wellness Holdings' value of 29.63 is 67.4% below this industry median. Based on the distribution chart, Ascend Wellness Holdings ranks #836 out of 920 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ascend Wellness Holdings has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ascend Wellness Holdings' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Ascend Wellness Holdings ranks #836 out of 920 companies for Days Payable. This places Ascend Wellness Holdings in the lower half of its industry. The industry median Days Payable is 90.84. Ascend Wellness Holdings' value of 29.63 is 67.4% below this benchmark. Historically, Ascend Wellness Holdings' own Days Payable has ranged from 11.99 to 32.45 over the past decade. While the company's 10-year median is 26.04 vs. the industry median of 90.84, Ascend Wellness Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ascend Wellness Holdings's current Days Payable of 29.63 is 67.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ascend Wellness Holdings and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascend Wellness Holdings's current Days Payable is 29.63, which is 14% above median its own 10-year median of 26.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascend Wellness Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ascend Wellness Holdings (AAWH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.64, compared to a current price of $0.47 — trading 26.9% below its estimated fair value. The current Days Payable is 29.63, which is 14% above median its 10-year median of 26.04 and 67.4% below the Drug Manufacturers industry median of 90.84. Ascend Wellness Holdings' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ascend Wellness Holdings (AAWH), the current Days Payable is 29.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ascend Wellness Holdings (AAWH) Overvalued in 2026?

Based on GuruFocus' analysis, Ascend Wellness Holdings stock appears to be undervalued. The current stock price of $0.47 is trading 26.9% below its estimated GF Value™ of $0.64. GuruFocus considers Ascend Wellness Holdings to be Possible Value Trap.

Key valuation signals for AAWH:

  • Days Payable: 29.63 (14% above median its 10-year median of 26.04)
  • GF Value™: $0.64 vs. price of $0.47 (26.9% below fair value)
  • GF Score™: 42/100 with 4 warning signs
  • Industry Position: 67.4% below the Drug Manufacturers median (#836 of 920)

No single metric tells the full story. See the AAWH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ascend Wellness Holdings Business Description

Other Exchanges 8VJ:GermanyAAWH.U:Canada
Address Rochelle Park, Morristown, NJ, USA, 07662
Ascend Wellness Holdings Inc is a vertically integrated multi-state operator focused on adult-use or near-term adult-use cannabis states in limited licenses markets. The company's core business is the cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which it sells through company-owned retail stores and third-party licensed cannabis retail stores. It generates maximum revenue from the retail product segment.
42GF Score

Get the complete analysis for AAWH

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.47
Price
$0.64
GF Value